Akebia Therapeutics, Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Akebia Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2016 to 2023.
  • Akebia Therapeutics, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $18.5M.
  • Akebia Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$25.2M, a 273% decline from 2022.
  • Akebia Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $14.6M, a 89.1% decline from 2021.
  • Akebia Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $134M, a 42.3% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$25.2M -$39.8M -273% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-14
2022 $14.6M -$119M -89.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-14
2021 $134M -$98M -42.3% Jan 1, 2021 Dec 31, 2021 10-K/A 2023-08-28
2020 $232M +$143M +160% Jan 1, 2020 Dec 31, 2020 10-K/A 2023-08-28
2019 $89M -$7.59M -7.86% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 $96.6M -$19.7M -16.9% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 $116M +$49.3M +73.6% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-12
2016 $66.9M Jan 1, 2016 Dec 31, 2016 10-K 2019-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.